Abbott (ABT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Abbott debuts FreeStyle Libre 3 Plus in Canada, enhancing diabetes care with the world's smallest glucose sensor.
Abbott Laboratories (NYSE:ABT) has greatly exceeded the broader S&P 500 index this year, with its stock price increasing by 18% compared to the S&P 500's 6% rise. This strong performance is due to the company's solid quarterly results and positive future forecasts.
![]() ABT In 4 days Announced | Quarterly | $0.59 Per Share |
![]() ABT 2 months ago Paid | Quarterly | $0.59 Per Share |
![]() ABT 5 months ago Paid | Quarterly | $0.59 Per Share |
![]() ABT 8 months ago Paid | Quarterly | $0.55 Per Share |
![]() ABT 11 months ago Paid | Quarterly | $0.55 Per Share |
17 Jul 2025 (In 6 days) Date | | 1.26 Cons. EPS | - EPS |
16 Jul 2025 (In 5 days) Date | | 1.25 Cons. EPS | - EPS |
15 Apr 2025 Date | | - Cons. EPS | - EPS |
22 Jan 2025 Date | | 1.34 Cons. EPS | 1.34 EPS |
16 Oct 2024 Date | | 1.2 Cons. EPS | 1.21 EPS |
![]() ABT In 4 days Announced | Quarterly | $0.59 Per Share |
![]() ABT 2 months ago Paid | Quarterly | $0.59 Per Share |
![]() ABT 5 months ago Paid | Quarterly | $0.59 Per Share |
![]() ABT 8 months ago Paid | Quarterly | $0.55 Per Share |
![]() ABT 11 months ago Paid | Quarterly | $0.55 Per Share |
17 Jul 2025 (In 6 days) Date | | 1.26 Cons. EPS | - EPS |
16 Jul 2025 (In 5 days) Date | | 1.25 Cons. EPS | - EPS |
15 Apr 2025 Date | | - Cons. EPS | - EPS |
22 Jan 2025 Date | | 1.34 Cons. EPS | 1.34 EPS |
16 Oct 2024 Date | | 1.2 Cons. EPS | 1.21 EPS |
Medical - Devices Industry | Healthcare Sector | Robert B. Ford CEO | XWBO Exchange | US0028241000 ISIN |
US Country | 114,000 Employees | 15 Jul 2025 Last Dividend | 2 Jan 2013 Last Split | 13 Jan 1978 IPO Date |
Abbott Laboratories is a global healthcare company that engages in the discovery, development, manufacturing, and sale of a wide range of health care products. With its foundation laid in 1888, and headquartered in North Chicago, Illinois, the company has established a significant presence worldwide. Abbott operates across four main sectors: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices, catering to a diverse range of healthcare needs from generic pharmaceuticals to advanced medical devices.
Abbott Laboratories offers a comprehensive portfolio of products and services across various healthcare domains: